Comparison of Effectiveness of Low Dose Laser and Transcutaneous Electrical Stimulation in Hemiplegic Shoulder
Comparison of the Efficacy of Low-Dose Laser and Transcutaneous Electrical Nerve Stimulation in Subacute Hemiplegic Shoulder Pain, and the Effect of Treatments on Upper Extremity Function and Quality of Life
Ankara Etlik City Hospital
45 participants
Sep 24, 2025
INTERVENTIONAL
Summary
The primary aim of this study is to compare the efficacy of Transcutaneous Electrical Nerve Stimulation (TENS) and Low Level Laser Therapy (LLLT), which are analgesic modalities that play an important role in the treatment of this frequently encountered complication. The secondary aim of the study is to evaluate its effectiveness on upper extremity function, quality of life, sleep, and fatigue.
Eligibility
Inclusion Criteria4
- Patients aged 18-75 years
- Patients with shoulder pain on the hemiplegic side *Mini mental state examination ≥ 25
- History of stroke within the last 2 weeks to 6 months
- Patients with shoulder pain scoring 40-100 points on the visual analogue scale (moderate to severe) will be included.
Exclusion Criteria14
- Patients who refuse to provide written consent or attend follow-up visits
- Being under 18 years of age
- Patients with motor aphasia
- Patients who have had a shoulder injection within the last 3 months
- Patients who have undergone upper extremity botulinum toxin application within the last 6 months
- *Pregnant women or those planning to become pregnant
- Inflammatory rheumatic disease
- Patients who have undergone shoulder injury and surgery prior to stroke
- Patients with other conditions that could explain shoulder pain
- Patients with complex regional pain syndrome
- Patients with a history of epilepsy, pacemaker, or arrhythmia diagnosis
- Malignancy
- Diseases such as Alzheimer's or dementia that cause cognitive impairment -History of psychiatric disorders such as major depression or personality disorders
- Alcohol and drug addiction
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients with subacromial-subdeltoid bursa, m. deltoideus, m. biceps longus, m. infraspinatus, and m. supraspinatus muscles (at the most painful point of the muscles) with a 13-diode Gallium-Aluminium-Arsenide laser device (Intelect Mobile Laser) with a wavelength of 850 nm and 50 mW, 4 Joules per day, 20 seconds, for a total of 15 laser sessions.
TENS therapy will be administered using the TENS device (Intelect Advanced Therapy System) for a total of 15 sessions, 5 days a week, 20 minutes per day, at a dose of 20-40 mA.
Only conventional physiotherapy is planned to be administered to patients.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07203222